Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab

Thomas E. Delea, Paul Tappenden, Oleg Sofrygin, Dominy Browning, Mayur Mohan Amonkar, Jonathan Karnon, Mel Walker, David Cameron

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Fingerprint Dive into the research topics of 'Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab'. Together they form a unique fingerprint.

Medicine & Life Sciences